New Perspectives in Rheumatology: May You Live in Interesting Times: Challenges and Opportunities in Lupus Research

Overview

Journal Arthritis Rheumatol

Publisher Wiley

Specialty Rheumatology

Date 2017 Apr 4

PMID 28371318

Citations 5

Authors

Inaki Sanz

Affiliations

Soon will be listed here.

Citing Articles

Different Spatial and Temporal Roles of Monocytes and Monocyte-Derived Cells in the Pathogenesis of an Imiquimod Induced Lupus Model.

Nomura A, Mizuno M, Noto D, Aoyama A, Kuga T, Murayama G Front Immunol. 2022; 13:764557.

PMID: 35371102 PMC: 8964788. DOI: 10.3389/fimmu.2022.764557.

New Frontiers: ARID3a in SLE.

Garton J, Barron M, Ratliff M, Webb C Cells. 2019; 8(10).

PMID: 31554207 PMC: 6830313. DOI: 10.3390/cells8101136.

Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients.

Idborg H, Zandian A, Ossipova E, Wigren E, Preger C, Mobarrez F Front Immunol. 2019; 10:1029.

PMID: 31156624 PMC: 6533644. DOI: 10.3389/fimmu.2019.01029.

SLE: reconciling heterogeneity.

Lockshin M, Barbhaiya M, Izmirly P, Buyon J, Crow M Lupus Sci Med. 2019; 6(1):e000280.

PMID: 31080630 PMC: 6485210. DOI: 10.1136/lupus-2018-000280.

DNA as a self-antigen: nature and regulation.

Soni C, Reizis B Curr Opin Immunol. 2018; 55:31-37.

PMID: 30261321 PMC: 6317730. DOI: 10.1016/j.coi.2018.09.009.

References

Jacquemin C, Schmitt N, Contin-Bordes C, Liu Y, Narayanan P, Seneschal J . OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response. Immunity. 2015; 42(6):1159-70. PMC: 4570857. DOI: 10.1016/j.immuni.2015.05.012. View

Clowse M, Wallace D, Furie R, Petri M, Pike M, Leszczynski P . Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials. Arthritis Rheumatol. 2016; 69(2):362-375. PMC: 5299488. DOI: 10.1002/art.39856. View

Wang D, Zhang H, Liang J, Li X, Feng X, Wang H . Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant. 2014; 22(12):2267-77. PMC: 11849135. DOI: 10.3727/096368911X582769c. View

Liarski V, Kaverina N, Chang A, Brandt D, Yanez D, Talasnik L . Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci Transl Med. 2014; 6(230):230ra46. PMC: 4129446. DOI: 10.1126/scitranslmed.3008146. View

Oon S, Wilson N, Wicks I . Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway. Clin Transl Immunology. 2016; 5(5):e79. PMC: 4910120. DOI: 10.1038/cti.2016.26. View

Son M, Kim S, Diamond B . SLE-associated risk factors affect DC function. Immunol Rev. 2015; 269(1):100-17. PMC: 4685736. DOI: 10.1111/imr.12348. View

Xiao X, Lao X, Chen M, Liu R, Wei Y, Ouyang F . PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression. Cancer Discov. 2016; 6(5):546-59. DOI: 10.1158/2159-8290.CD-15-1408. View

Sui W, Hou X, Che W, Yang M, Dai Y . The applied basic research of systemic lupus erythematosus based on the biological omics. Genes Immun. 2013; 14(3):133-46. DOI: 10.1038/gene.2013.3. View

Teruel M, Alarcon-Riquelme M . The genetic basis of systemic lupus erythematosus: What are the risk factors and what have we learned. J Autoimmun. 2016; 74:161-175. DOI: 10.1016/j.jaut.2016.08.001. View

10.

Medina-Quinones C, Ramos-Merino L, Ruiz-Sada P, Isenberg D . Analysis of Complete Remission in Systemic Lupus Erythematosus Patients Over a 32-Year Period. Arthritis Care Res (Hoboken). 2015; 68(7):981-7. DOI: 10.1002/acr.22774. View

11.

Cervera R, Doria A, Amoura Z, Khamashta M, Schneider M, Guillemin F . Patterns of systemic lupus erythematosus expression in Europe. Autoimmun Rev. 2014; 13(6):621-9. DOI: 10.1016/j.autrev.2013.11.007. View

12.

Lim S, Bayakly A, Helmick C, Gordon C, Easley K, Drenkard C . The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry. Arthritis Rheumatol. 2014; 66(2):357-68. PMC: 4617771. DOI: 10.1002/art.38239. View

13.

Menon M, Blair P, Isenberg D, Mauri C . A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus. Immunity. 2016; 44(3):683-697. PMC: 4803914. DOI: 10.1016/j.immuni.2016.02.012. View

14.

Barrat F, Elkon K, Fitzgerald K . Importance of Nucleic Acid Recognition in Inflammation and Autoimmunity. Annu Rev Med. 2015; 67:323-36. DOI: 10.1146/annurev-med-052814-023338. View

15.

Carter E, Barr S, Clarke A . The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol. 2016; 12(10):605-20. DOI: 10.1038/nrrheum.2016.137. View

16.

Waibel M, Christiansen A, Hibbs M, Shortt J, Jones S, Simpson I . Manipulation of B-cell responses with histone deacetylase inhibitors. Nat Commun. 2015; 6:6838. DOI: 10.1038/ncomms7838. View

17.

Davidson A . What is damaging the kidney in lupus nephritis?. Nat Rev Rheumatol. 2015; 12(3):143-53. PMC: 4820834. DOI: 10.1038/nrrheum.2015.159. View

18.

Stamatiades E, Tremblay M, Bohm M, Crozet L, Bisht K, Kao D . Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages. Cell. 2016; 166(4):991-1003. PMC: 4983224. DOI: 10.1016/j.cell.2016.06.058. View

19.

Teichmann L, Cullen J, Kashgarian M, Dong C, Craft J, Shlomchik M . Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus. Immunity. 2015; 42(3):552-65. PMC: 4456685. DOI: 10.1016/j.immuni.2015.02.015. View

20.

Feldman C, Costenbader K . Editorial: A Stalemate in Lupus-Related End-Stage Renal Disease: Can We Do Better?. Arthritis Rheumatol. 2016; 68(6):1323-6. DOI: 10.1002/art.39593. View